Why would overexpression of an MDR transporter in a cancer...

Labs

Want to see this concept in action?

NEW

Explore this concept interactively to see how it behaves as you change inputs.

View Labs

Key Concepts

Chemotherapy Resistance

Chemotherapy resistance is a major challenge in cancer treatment, where cancer cells develop strategies to evade the cell-killing effects of drugs. The overexpression of drug efflux transporters contributes significantly to this resistance, making standard chemotherapy less effective and the cancer more difficult to treat.

Drug Efflux Mechanism

The drug efflux mechanism is a cellular process where drugs are expelled from inside the cell to the outside, often through active transport. This mechanism is a key factor in chemotherapy resistance because it prevents drugs from accumulating to therapeutic levels within cancer cells.

Multidrug Resistance (MDR)

Multidrug resistance refers to the phenomenon where cancer cells develop the ability to withstand the effects of various chemotherapeutic agents. This resistance is often due to multiple cellular adaptations that allow the cells to survive treatments that would normally be lethal.

Transporter Proteins

Transporter proteins are integral membrane proteins that move substances across the cell membrane. In the context of cancer, certain transporter proteins become overexpressed, enabling cells to actively pump out chemotherapy drugs, thereby reducing the drugs' intracellular concentrations and effectiveness.

Transcript

Please give Ace some feedback